Heart Failure in Hispanics

Journal of the American College of Cardiology

Volumn 53, Issue 14, 2009, Pages 1167-1175

  Vivo, Rey P ^a   Krim, Selim R ^a   Cevik, Cihan ^a   Witteles, Ronald M ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy; ethnic disparity; heart failure; Hispanic; insulin resistance

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHAGAS DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CULTURAL FACTOR; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNICITY; GLYCEMIC CONTROL; HEALTH CARE; HEART FAILURE; HISPANIC; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LINGUISTICS; METABOLIC SYNDROME X; OBESITY; OUTCOME ASSESSMENT; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RACE; REVIEW; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS;

HEART FAILURE; HISPANIC AMERICANS; HUMANS; INSULIN RESISTANCE; PATIENT READMISSION; RISK FACTORS;

EID: 63149150757     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.037     Document Type: Review

References (106)

1. U.S. Census Bureau. Population Estimates. http://www.census.gov Accessed August 27, 2008
2. Pleis J.R., and Lethbridge-Çejku M. Summary health statistics for U.S. adults: national health interview survey, 2005. National Center for Health Statistics. Vital Health Stat 10(232). 2006 [online publication]. http://www.cdc.gov/nchs/data/series/sr_10/sr10_232.pdf Accessed October 24, 2008
3. Rosamond W., Flegal K., Friday G., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
4. Mensah G.A., Mokdad A.H., Ford E.S., Greenlund K.J., and Croft J.B. State of disparities in cardiovascular health in the United States. Circulation 111 (2005) 1233-1241
5. Weinick R.M., Jacobs E.A., Stone L.C., Ortega A.N., and Burstin H. Hispanic healthcare disparities: challenging the myth of a monolithic Hispanic population. Med Care 42 (2004) 313-320
6. Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. 2006 [online publication]. http://www.whitehouse.gov/omb/fedreg/ombdir15.html Accessed on April 2, 2008
7. Taylor A.L., and Wright J.T. Importance of race/ethnicity in clinical trials. Circulation 112 (2005) 3654-3660
8. Novello A.C., Wise P.H., and Kleinman D.V. Hispanic health: time for data, time for action. JAMA 265 (1991) 253-255
9. Lauderdale D.S., and Goldberg J. The expanded racial and ethnic codes in the Medicare data files: their completeness of coverage and accuracy. Am J Public Health 86 (1996) 712-716
10. Demirovic J., Prineas R., and Rudolph M. Epidemiology of congestive heart failure in three ethnic groups. Congest Heart Fail 7 (2001) 93-96
11. Bahrami H., Kronmal R., Bluemke D.A., et al. Differences in the incidence of congestive heart failure by ethnicity. Arch Intern Med 168 (2008) 2138-2145
12. Alexander M., Grumbach K., Remy L., Rowell R., and Massie B.M. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J 137 (1999) 919-927
13. Minutello R.M., Chou E.T., Hong M.K., and Wong S.C. Impact of race and ethnicity on inhospital outcomes after percutaneous coronary intervention: report from the 2000-2001 New York State Angioplasty Registry. Am Heart J 151 (2006) 164-167
14. Yeo K.K., Li Z., and Amsterdam E. Clinical characteristics and 30-day mortality among Caucasians, Hispanics, Asians and African-Americans in the 2003 California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol 100 (2007) 59-63
15. Jimenez J., Osorio J.M., Andrade S., Bauerlein J., Mallon S., and Yancy C. Decompensated heart failure among Hispanic Americans: a report from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail 10 Suppl 1 (2004) S93
16. Aronow W.S., Ahn C., and Kronzon I. Comparison of echocardiographic abnormalities in African-American, Hispanic, and White men and women aged >60 years. Am J Cardiol 87 (2001) 1131-1133
17. Ingelsson E., Arnlov J., Sundstrom J., Zethelius B., Vessby B., and Lind L. Novel metabolic risk factors for heart failure. J Am Coll Cardiol 46 (2005) 2054-2060
18. Bahrami H., Bluemke D.A., Kronmal R., et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 51 (2008) 1775-1783
19. Centers for Disease Control and Prevention. Prevalence of diabetes among Hispanics: selected areas, 1998-2002. MMWR Morb Mortal Wkly Rep 53 (2004) 941-944
20. Venkat Narayan K.M., Boyle J.P., Geiss L.S., Saaddine J.B., and Thompson T.J. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29 (2006) 2114-2116
21. Ramachandran A., Snehalatha C., Viswanathan V., Viswanathan M., and Haffner S.M. Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract 36 (1997) 121-125
22. Haffner S.M., Knapp J.A., Hazuda H.P., Stern M.P., and Young E.A. Dietary intakes of macronutrients among Mexican Americans and Anglo Americans: the San Antonio Heart Study. Am J Clin Nutr 42 (1985) 1266-1275
23. Mitchell B.D., Kammerer C.M., Blangero J., et al. Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. The San Antonio Family Heart Study. Circulation 94 (1996) 2159-2170
24. Lorenzo C., Serrano-Rios M., Martinez-Larrad M.T., et al. Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in Mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care 24 (2001) 2059-2064
25. Stern M.P., and Haffner S.M. Type II diabetes and its complications in Mexican Americans. Diabetes Metab Rev 6 (1990) 29-45
26. Carter J.S., Pugh J.A., and Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 125 (1996) 221-232
27. Harris M.I., Eastman R.C., Cowie C.C., Flegal K.M., and Eberhardt M.S. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22 (1999) 403-408
28. Haffner S.M., Hazuda H.P., Stern M.P., Patterson J.K., Van Heuven W.A.J., and Fong D. Effect of socioeconomic status on hyperglycemia and retinopathy levels in Mexican Americans with NIDDM. Diabetes Care 12 (1989) 128-134
29. Lasater L.M., Davidson A.J., Steiner J.F., and Mehler P.S. Glycemic control in English- vs Spanish-speaking Hispanic patients with type 2 diabetes mellitus. Arch Intern Med 161 (2001) 77-82
30. Heisler M., Faul J.D., Hayward R.A., Langa K.M., Blaum C., and Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med 167 (2007) 1853-1860
31. Stratton I.M., Adler A.I., Neil H.A.W., et al., U.K. Prospective Diabetes Study Group. Association of glycaemia with microvascular and macrovascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
32. Hayat S.A., Patel B., Khattar R.S., and Malik R.A. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci 107 (2004) 539-557
33. Bertoni A.G., Goff Jr. D.C., D'Agostino Jr. R.B., et al. Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 29 (2006) 588-594
34. Pawson I.G., Martorell R., and Mendoza F.E. Prevalence of overweight and obesity in U.S. Hispanic populations. Am J Clin Nutr 53 Suppl (1991) 1522S-1528S
35. Kenchaiah S., Evans J.C., Levy D., et al. Obesity and risk of heart failure. N Engl J Med 347 (2002) 305-313
36. Grassi G., Seravalle G., Quarti-Trevano F., et al. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome. Characteristics and mechanisms. Hypertension 49; (2007) 535-541
37. Vasan R.S., Sullivan L.M., Roubenoff R., et al., on behalf of the Framingham Heart Study Investigators. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107 (2003) 1486-1491
38. Alpert M.A., Lambert C.R., Panayiotou H., et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76 (1995) 1194-1197
39. Poirier P., Giles T.D., Bray G.A., et al., on behalf of American Heart Association and Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006) 898-918
40. Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
41. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., Woo M.A., and Tillisch J.H. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001) 789-795
42. Davos C.H., Doehner W., Rauchhaus M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003) 29-35
43. Lavie C.J., Osman A.F., Milani R.V., and Mehra M.R. Body composition prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003) 891-894
44. Oreopoulos A., Padwal R., Kalantar-Zadeh K., Fonarow G.C., Norris C.M., and McAlister F.A. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156 (2008) 13-22
45. Kalantar-Zadeh K., Block G., Horwich T., and Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
46. Haffner S.M., Morales P.A., Hazuda H.P., and Stern M.P. Level of control of hypertension in Mexican Americans and non-Hispanic whites. Hypertension 21 (1993) 83-88
47. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the U.S. adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25 (1995) 305-313
48. Kannel W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 275 (1996) 1571-1576
49. Kamalesh M. Heart failure in diabetes and related conditions. J Card Fail 13 (2007) 861-873
50. Haffner S.M., Stern M.P., Hazuda H.P., Rosenthal M., and Knapp J.A. The role of behavioral variables and fat patterning in explaining ethnic differences in serum lipids and lipoproteins. Am J Epidemiol 123 (1986) 830-839
51. Haffner S.M., Mykkänen L., Valdez R.A., Paidi M., Stern M.P., and Howard B.V. LDL size and subclass pattern in a biethnic population. Arterioscler Thromb Vasc Biol 13 (1993) 1623-1630
52. Grundy S.M. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 95 (1997) 1-4
53. Kannel W.B., and Belanger A.J. Epidemiology of heart failure. Am Heart J 121 (1991) 951-957
54. Horwich T.B., Hamilton M.A., MacLellan W.R., and Fonarow G.C. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
55. Rauchhaus M., Clark A.L., Doehner W., et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42 (2003) 1933-1940
56. Christ M., Klima T., Grimm W., Mueller H.H., and Maisch B. Prognostic significance of serum cholesterol levels in patients with dilated cardiomyopathy. Eur Heart J 27 (2006) 691-699
57. Rauchhaus M., Coats A.J.S., and Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 356 (2000) 930-933
58. Cleland J.G.F., Loh H., Windram J., Goode K., and Clark A.L. Threats, opportunities, and statins in the modern management if heart failure. Eur Heart J 27 (2006) 641-643
59. Kjekshus J., Pedersen T.R., Olsson A.G., Faergeman O., and Pyorala K. The effects of simvastatin on the incidence of heart failure in patients with coronary artery disease. J Card Fail 3 (1997) 249-254
60. Kjekshus J., Apetrei E., Barrios V., et al., for the CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 (2007) 2248-2261
61. GISSI-HF Investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008) 1231-1239
62. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among U.S. adults. JAMA 287 (2002) 356-359
63. Langefeld C.D., Wagenknecht L.E., Rotter J.I., et al., on behalf of Insulin Resistance Atherosclerosis Study Family Study Investigators. Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 53 (2004) 1170-1174
64. Chandalia M., Grundy S.M., Adams-Huet B., and Abate N. Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort. J Diabetes Complicat 21 (2007) 143-148
65. Witteles R.M., and Fowler M.B. Insulin-resistant cardiomyopathy: clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 51 (2008) 93-102
66. Sundstrom J., Arnlov J., Stolare K., and Lind L. Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study. Heart 94 (2008) 874-878
67. Ingelsson E., Arnlov J., Lind L., and Sundstrom J. Metabolic syndrome and risk for heart failure in middle aged men. Heart 92 (2006) 1409-1413
68. Budoff M.J., Yang T.P., Shavelle R.M., Lamont D.H., and Brundage B.H. Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol 39 (2002) 408-412
69. D'Agostino Jr. R.B., Burke G., O'Leary D., et al. Ethnic differences in carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Stroke 27 (1996) 1744-1749
70. Becker T.M., Wiggins C., Key C.R., and Samet J.M. Ischemic heart disease mortality in Hispanics, American Indians, and non-Hispanic whites in New Mexico, 1958-1982. Circulation 78 (1988) 302-309
71. Mitchell B.D., Stern M.P., Haffner S.M., Hazuda H.P., and Patterson J.K. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol 131 (1990) 423-433
72. Liao Y., Cooper R.S., Cao G., Kaufman J.S., Long A.E., and McGee D.L. Mortality from coronary heart disease and cardiovascular disease among adult U.S. Hispanics: findings from the National Health Interview Survey (1986 to 1994). J Am Coll Cardiol 30 (1997) 1200-1205
73. Swenson C.J., Trepka M.J., Rewers M.J., Scarbro S., Hiatt W.R., and Hamman R.F. Cardiovascular disease mortality in Hispanics and non-Hispanic Whites. Am J Epidemiol 156 (2002) 919-928
74. Pandey D.K., Labarthe D.R., Goff D.C., Chan W., and Nichaman M.Z. Community-wide coronary heart disease mortality in Mexican Americans equals or exceeds that in non-Hispanic whites: the Corpus Christi Heart Project. Am J Med 110 (2001) 81-87
75. Hunt K.J., Resendez R.G., Williams K., Haffner S.M., Stern M.P., and Hazuda H.P. All-cause and cardiovascular mortality among Mexican-American and non-Hispanic white older participants in the San Antonio Heart Study-evidence against the "Hispanic Paradox.". Am J Epidemiol 158 (2003) 1048-1057
76. Shaw L.J., Shaw R.E., Merz C.N., et al., for the American College of Cardiology-National Cardiovascular Data Registry Investigators. Impact of ethnicity and sex differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 117 (2008) 1787-1801
77. Becker T.M., Wiggins C.L., Key C.R., and Samet J.M. Ethnic differences in mortality from acute rheumatic fever and chronic rheumatic heart disease in New Mexico, 1958-1982. West J Med 150 (1989) 46-50
78. DiGiorgi P.L., Baumann F.G., O'Leary A.M., et al. Differences in mitral valve disease presentation and surgical treatment outcome between Hispanic and non-Hispanic patients. Ethn Dis 18 (2008) 306-310
79. Hanford E.J., Zhan F.B., Lu Y., and Giordano A. Chagas disease in Texas: recognizing the significance and implications of evidence in the literature. Soc Sci Med 65 (2007) 60-79
80. Leiby D.A., Rentas F.J., Nelson K.E., et al. Evidence of Trypanosoma cruzi infection (Chagas' disease) among patients undergoing cardiac surgery. Circulation 102 (2000) 2978-2982
81. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 (2007) Suppl:75-85
82. Milei J., Mautner B., Storino R., Sanchez J.A., and Ferrans V.J. Does Chagas' disease exist as an undiagnosed form of cardiomyopathy in the United States?. Am Heart J 123 (1992) 1732-1735
83. Hagar J.M., and Rahimtoola S.H. Chagas' heart disease in the United States. N Engl J Med 325 (1991) 763-768
84. Correa-de-Araujo R., Stevens B., Moy E., Nilasena D., Chesley F., and McDermott K. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Womens Health Issues 16 (2006) 44-55
85. Albert N.M., Fonarow G.C., Abraham W.T., et al. Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF. J Card Fail 13 (2007) 189-198
86. Yancy C.W., Fonarow G.C., LaBresh K.A., et al. Disparate quality of care for black and Hispanic heart failure patients: a report from Get With the Guidelines-Heart Failure (GWTG-HF). (abstr). J Card Fail 13 Suppl 2 (2007) S157
87. Brown D.W., Haldeman G.A., Croft J.B., Giles W.H., and Mensah G.A. Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990-2000. Am Heart J 150 (2005) 448-454
88. Riegel B., Moser D.K., Rayens M.K., et al., on behalf of the Heart Failure Trialists Collaborators. Ethnic differences in quality of life in persons with heart failure. J Card Fail 14 (2008) 41-47
89. Department of Health and Human Services. Healthy People 2010. 2nd edition (2000), U.S. Government Printing Office, Washington, DC
90. Davis A.M., Vinci L.M., Okwuosa T.M., Chase A.R., and Huang E.S. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev 64 (2007) Suppl:29S-100S
91. Trevino F.M., Moyer M.E., Valdez R.B., and Stroup-Benham C.A. Health insurance coverage and utilization of health services by Mexican Americans, mainland Puerto Ricans, and Cuban Americans. JAMA 265 (1991) 233-237
92. Solis J.M., Marks G., Garcia M., and Shelton D. Acculturation, access to care, and use of preventive services by Hispanics: findings from HHANES 1982-84. Am J Public Health 80 (1990) Suppl:11-9
93. Bolen J.C., Rhodes L., Powell-Griner E.E., Bland S.D., and Holtzman D. State-specific prevalence of selected health behaviors, by race and ethnicity-Behavioral Risk Factor Surveillance System, 1997. MMWR CDC Surveill Summ 49 (2000) 1-60
94. Jurkowski J.M., and Johnson T.P. Acculturation and cardiovascular disease screening practices among Mexican Americans living in Chicago. Ethn Dis 15 (2005) 411-417
95. Institute of Medicine. The health, health insurance and language status of racial and ethnic minority populations. In: Smedley B.D., Stith A.Y., and Nelson A.R. (Eds). Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (2003), National Academes Press, Washington, DC 88-89
96. DuBard C.A., Garrett J., and Gizlice Z. Effect of language on heart attack and stroke awareness among U.S. Hispanics. Am J Prev Med 30 (2006) 189-196
97. Seijo R., Gomez H., and Freidenberg J. Language as a communication barrier in medical care for Hispanic patients. Hisp J Behav Sci 13 (1991) 363-366
98. Balsa A.I., and McGuire T.G. Prejudice, clinical uncertainty and stereotyping as sources of health disparities. J Health Econ 22 (2003) 89-116
99. Larkey L.K., Hecht M.L., Miller K., and Alatorre C. Hispanic cultural norms for health-seeking behaviors in the face of symptoms. Health Educ Behav 28 (2001) 65-80
100. Ontiveros J.A., Black S.A., Jakobi P.L., and Goodwin J.S. Ethnic variation in attitudes toward hypertension in adults ages 75 and older. Prev Med 29 (1999) 443-449
101. Evelyn B., Toigo T., Banks D., et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. J Natl Med Assoc 93 (2001) Suppl:18S-24S
102. Oddone E.Z., Olsen M.K., Lindquist J.H., et al. Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000). Control Clin Trials 25 (2004) 378-387
103. Wendler D., Kington R., Madans J., et al. Are racial and ethnic minorities less willing to participate in health research?. PLoS Med 3 (2006) e19
104. Sabri A.A., and Qayyum M.A. Increasing the participation: another factor. PLoS Med 3 (2006) e250
105. Davidson J.A., Kannel W.B., Lopez-Candales A., et al. Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to action. J Cardiometab Syndr 2 (2007) 238-243
106. Jensen M.D. What is the potential role of cannabinoid-1 receptor blockade in glucose and lipid management?. Am J Med 120 (2007) Suppl 1:S25-32